Diagnosis and treatment in Helicobacter pylori infection

Area of Science:

• Microbiology and Infectious Diseases
• Gastroenterology
• Public Health

Background:

• Helicobacter pylori is the most common chronic bacterial infection globally, affecting up to 50% of the world's population.
• Prevalence varies significantly, with higher rates in Romania (90-94%) compared to Western countries (<50-60%), influenced by socioeconomic factors and healthcare advancements.
• Untreated H. pylori infection persists lifelong and can lead to severe gastric conditions, including ulcers (10-11%), premalignant changes (5-6%), and gastric cancer (1%).

Purpose of the Study:

• To underscore the critical importance of detecting and treating Helicobacter pylori infections due to their high prevalence and potential severe health consequences.
• To review the diverse diagnostic methods for H. pylori, emphasizing factors influencing selection such as invasiveness, cost, and clinical context.
• To highlight the rationale for developing a vaccine against H. pylori, aiming to improve eradication rates and reduce the socioeconomic burden of associated diseases.

Main Methods:

• The study is a review and discussion of existing knowledge on Helicobacter pylori infection.
• It analyzes various diagnostic approaches, considering their accessibility, advantages, disadvantages (invasive vs. non-invasive), cost, and intended use (diagnosis, epidemiology, treatment efficacy).
• Clinical factors such as patient age, history, symptoms, psychological state, and concurrent treatments are noted as important considerations for diagnosis.

Main Results:

• The abstract does not present specific study results but discusses the established knowledge regarding H. pylori prevalence, associated pathologies, and diagnostic/treatment strategies.
• It highlights the high failure rate of current H. pylori eradication therapies, justifying the search for alternative solutions.
• The significant socioeconomic costs associated with managing H. pylori-related diseases are emphasized.

Conclusions:

• The detection and treatment of Helicobacter pylori infection are strongly justified by its high prevalence and severe potential sequelae.
• The development of a vaccine for H. pylori is proposed as an attractive strategy for both prevention and treatment, addressing the limitations of current therapies and reducing healthcare costs.
• A dual-role vaccine could mitigate the socioeconomic burden of gastric ulcers and cancers linked to H. pylori infection.